Temat: "Precision" - OpacWWW

Skocz do pozycji: 41.

Tytuł:: Considerations for pooling real-world data as a comparator cohort to a single arm trial: a simulation study on assessment of heterogeneity.
Autorzy:: Backenroth D; Janssen Research & Development, Titusville, USA.
Royce T; Flatiron Health, Inc, 233 Spring Street, New York, NY, 10013, USA.
Pinheiro J; Janssen Research & Development, Titusville, USA.
Samant M; Flatiron Health, Inc, 233 Spring Street, New York, NY, 10013, USA.
Humblet O; Flatiron Health, Inc, 233 Spring Street, New York, NY, 10013, USA. .; Pokaż więcej
Źródło:: BMC medical research methodology [BMC Med Res Methodol] 2023 Aug 24; Vol. 23 (1), pp. 193. Date of Electronic Publication: 2023 Aug 24.
Typ publikacji:: Meta-Analysis; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Medical Oncology*
Precision Medicine*
Humans ; Computer Simulation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 42.

Tytuł:: cRGD-Conjugated GdIO Nanoclusters for the Theranostics of Pancreatic Cancer through the Combination of T 1 -T 2 Dual-Modal MRI and DTX Delivery.
Autorzy:: Wang S; Department of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar 161006, China.
Qi G; Department of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar 161006, China.
Zhang Z; Department of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar 161006, China.
Yin Q; Department of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar 161006, China.
Li N; Department of Imaging Medicine and Nuclear Medicine, School of Clinical Medicine, Jiamusi University, Jiamusi 154002, China.
Li Z; Department of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar 161006, China.
Shi G; Department of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar 161006, China.
Hu H; Medical Imaging Center, The Second Affiliated Hospital of Qiqihar Medical University, Qiqihar 161000, China.
Hao L; Department of Molecular Imaging, School of Medical Technology, Qiqihar Medical University, Qiqihar 161006, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2023 Aug 18; Vol. 28 (16). Date of Electronic Publication: 2023 Aug 18.
Typ publikacji:: Journal Article
MeSH Terms:: Precision Medicine*
Pancreatic Neoplasms*/diagnostic imaging
Pancreatic Neoplasms*/drug therapy
Humans ; Docetaxel ; Gadolinium ; Magnetic Resonance Imaging ; Iron ; Tumor Microenvironment ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 43.

Tytuł:: Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine.
Autorzy:: Benfaremo D; Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy.; Clinica Medica, Department of Internal Medicine, Marche University Hospital, 60126 Ancona, Italy.
Agarbati S; Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy.
Mozzicafreddo M; Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy.
Paolini C; Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy.
Svegliati S; Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy.; Clinica Medica, Department of Internal Medicine, Marche University Hospital, 60126 Ancona, Italy.
Moroncini G; Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy.; Clinica Medica, Department of Internal Medicine, Marche University Hospital, 60126 Ancona, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Aug 08; Vol. 24 (16). Date of Electronic Publication: 2023 Aug 08.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Precision Medicine*
Scleroderma, Systemic*/genetics
Scleroderma, Systemic*/therapy
Humans ; Transcriptome ; Skin ; Gene Expression Profiling

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 44.

Tytuł:: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.
Autorzy:: Lococo F; Catholic University of the Sacred Heart, Rome, Italy. .; Thoracic Surgery Unit, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy. .
Boldrini L; Catholic University of the Sacred Heart, Rome, Italy.; Radiotherapy Unit, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Diepriye CD; Radiotherapy Unit, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Evangelista J; Catholic University of the Sacred Heart, Rome, Italy.; Thoracic Surgery Unit, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Nero C; Catholic University of the Sacred Heart, Rome, Italy.; Division of Oncological Gynecology, Department of Woman and Child Health and Public Health, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Flamini S; Thoracic Surgery Unit, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Minucci A; Catholic University of the Sacred Heart, Rome, Italy.; Departmental Unit of Molecular and Genomic Diagnostics, Genomics Core Facility, Gemelli Science and Technology Park (G-STeP), A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
De Paolis E; Departmental Unit of Molecular and Genomic Diagnostics, Genomics Core Facility, Gemelli Science and Technology Park (G-STeP), A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.; Clinical Chemistry, Biochemistry and Molecular Biology Operations (UOC), A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Vita E; Catholic University of the Sacred Heart, Rome, Italy.; Medical Oncology, A. Gemelli University Hospital Foundation IRCCS, Largo A. Gemelli 8, Rome, Italy.
Cesario A; Catholic University of the Sacred Heart, Rome, Italy.; Open Innovation, Scientific Directorate, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.; CEO, Gemelli Digital Medicine & Health Srl, Rome, Italy.
Annunziata S; Catholic University of the Sacred Heart, Rome, Italy.; Nuclear Medicine Unit, GsteP Radiopharmacy TracerGLab, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Calcagni ML; Catholic University of the Sacred Heart, Rome, Italy.; Nuclear Medicine Unit, GsteP Radiopharmacy TracerGLab, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Chiappetta M; Catholic University of the Sacred Heart, Rome, Italy.; Thoracic Surgery Unit, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Cancellieri A; Catholic University of the Sacred Heart, Rome, Italy.; Institute of Pathology, A. Gemelli University Hospital Foundation IRCCS, Roma, Italy.
Larici AR; Catholic University of the Sacred Heart, Rome, Italy.; Advanced Radiodiagnostic Center, Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Cicchetti G; Catholic University of the Sacred Heart, Rome, Italy.; Advanced Radiodiagnostic Center, Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Troost EGC; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf, Rossendorf, Germany.; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, OncoRay - National Center for Radiation Research in Oncology, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz Association / Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
Ádány R; ELKH-DE Public Health Research Group, Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Farré N; Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (IR-HSCSP), Barcelona, Spain.
Öztürk E; School of Medicine, Turkey and Koç University Research Center for Translational Medicine (KUTTAM), Sariyer, Koç University, Istanbul, Turkey.
Van Doorne D; Department of Philosophy and Educational Sciences, University of Turin - Academy of the Expert Patient ADPEE - EUPATI, Turin, Italy.
Leoncini F; Catholic University of the Sacred Heart, Rome, Italy.; Interventional Pulmonology Unit, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Urbani A; Catholic University of the Sacred Heart, Rome, Italy.; Clinical Chemistry, Biochemistry and Molecular Biology Operations (UOC), A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.; Department of Basic Biotechnological Sciences, Intensivological and Perioperative Clinics, Catholic University of Sacred Heart, Rome, Italy.
Trisolini R; Catholic University of the Sacred Heart, Rome, Italy.; Interventional Pulmonology Unit, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Bria E; Catholic University of the Sacred Heart, Rome, Italy.; Medical Oncology, A. Gemelli University Hospital Foundation IRCCS, Largo A. Gemelli 8, Rome, Italy.
Giordano A; Catholic University of the Sacred Heart, Rome, Italy.; Nuclear Medicine Unit, GsteP Radiopharmacy TracerGLab, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Rindi G; Catholic University of the Sacred Heart, Rome, Italy.; Institute of Pathology, A. Gemelli University Hospital Foundation IRCCS, Roma, Italy.
Sala E; Catholic University of the Sacred Heart, Rome, Italy.; Advanced Radiodiagnostic Center, Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Tortora G; Catholic University of the Sacred Heart, Rome, Italy.; Medical Oncology, A. Gemelli University Hospital Foundation IRCCS, Largo A. Gemelli 8, Rome, Italy.
Valentini V; Catholic University of the Sacred Heart, Rome, Italy.; Radiotherapy Unit, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Boccia S; Catholic University of the Sacred Heart, Rome, Italy.; Department of Life Sciences and Public Health, Catholic University of Sacred Heart, Rome, Italy.
Margaritora S; Catholic University of the Sacred Heart, Rome, Italy.; Thoracic Surgery Unit, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.
Scambia G; Catholic University of the Sacred Heart, Rome, Italy.; Division of Oncological Gynecology, Department of Woman and Child Health and Public Health, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Jun 13; Vol. 23 (1), pp. 540. Date of Electronic Publication: 2023 Jun 13.
Typ publikacji:: Journal Article
MeSH Terms:: Precision Medicine*
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/therapy
Humans ; Artificial Intelligence ; Multiomics ; Quality of Life

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 45.

Tytuł:: Investigation of Clinically Significant Molecular Aberrations in Patients with Prostate Cancer: Implications for Personalized Treatment, Prognosis and Genetic Testing.
Autorzy:: Fountzilas E; Department of Medical Oncology, St. Lukes's Hospital, 55236 Thessaloniki, Greece.; Medical Oncology, German Oncology Center, European University Cyprus, Limassol 3036, Cyprus.
Kouspou M; Department of Basic and Clinical Sciences, University of Nicosia Medical School, Nicosia 2417, Cyprus.
Eliades A; Medicover Genetics, Nicosia 2409, Cyprus.
Papadopoulou K; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Bournakis E; Oncology Unit, 2nd Department of Surgery, Aretaieio Hospital, Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.; Oncologic Clinical Trials and Research Clinic, Metropolitan General Hospital, 15562 Athens, Greece.
Goussia A; Department of Pathology, Faculty of Medicine, Ioannina University Hospital, 45500 Ioannina, Greece.; Department of Pathology, German Oncology Center, Limassol 4108, Cyprus.
Tsiatas M; Department of Oncology, Athens Medical Center, 15125 Marousi, Greece.
Achilleos A; Medicover Genetics, Nicosia 2409, Cyprus.
Tsangaras K; Medicover Genetics, Nicosia 2409, Cyprus.
Billioud G; Medicover Genetics, Nicosia 2409, Cyprus.
Loizides C; Medicover Genetics, Nicosia 2409, Cyprus.
Lemesios C; Medicover Genetics, Nicosia 2409, Cyprus.
Kypri E; Medicover Genetics, Nicosia 2409, Cyprus.
Ioannides M; Medicover Genetics, Nicosia 2409, Cyprus.
Koumbaris G; Medicover Genetics, Nicosia 2409, Cyprus.
Levva S; Medical Oncology, Bioclinic of Thessaloniki, 54622 Thessaloniki, Greece.
Vakalopoulos I; First Department of Urology, School of Medicine, Aristotle University of Thessaloniki, 'G. Gennimatas' General Hospital, 54124 Thessaloniki, Greece.
Paliouras A; Department of Urology, Ioannina University Hospital, 45500 Ioannina, Greece.
Pervana S; Department of Pathology, Papageorgiou Hospital, 56429 Thessaloniki, Greece.
Koinis F; Department of Medical Oncology, University General Hospital of Larissa, 41110 Larissa, Greece.
Bumci R; Department of Pathology, Faculty of Medicine, Ioannina University Hospital, 45500 Ioannina, Greece.
Christopoulou A; Medical Oncology Unit, S. Andrew Hospital, 26332 Patras, Greece.
Meditskou S; Department of Histology-Embryology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Psyrri A; Section of Medical Oncology, Department of Internal Medicine, Attikon University Hospital, Faculty of Medicine, National and Kapodistrian University of Athens School of Medicine, 12462 Athens, Greece.
Boukovinas I; Medical Oncology, Bioclinic of Thessaloniki, 54622 Thessaloniki, Greece.
Visvikis A; Third Department of Medical Oncology, Agii Anargiri Cancer Hospital, 14564 Athens, Greece.
Karavasilis V; University College London Hospitals NHS Foundation Trust, London WC1N 3BG, UK.
Koukoulis GK; Department of Pathology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41100 Larissa, Greece.
Kotsakis A; Department of Medical Oncology, University General Hospital of Larissa, 41110 Larissa, Greece.
Giannakis D; Department of Urology, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Fountzilas G; Laboratory of Molecular Oncology, Hellenic Foundation for Cancer Research/Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.; Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.; Department of Medical Oncology, German Oncology Center, Limassol 4108, Cyprus.
Patsalis PC; Department of Basic and Clinical Sciences, University of Nicosia Medical School, Nicosia 2417, Cyprus.; Medicover Genetics, Nicosia 2409, Cyprus.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jul 23; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 23.
Typ publikacji:: Journal Article
MeSH Terms:: Precision Medicine*
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/therapy
Male ; Humans ; Aged ; Prospective Studies ; Genetic Testing

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 46.

Tytuł:: Radionuclide-based theranostics - a promising strategy for lung cancer.
Autorzy:: Zhu T; Department of Respiratory Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, Zhejiang, China.; Lingang Laboratory, Shanghai, 200031, China.
Hsu JC; Departments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Guo J; Department of Interventional Medicine, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, 519000, Guangdong, China.
Chen W; Department of Respiratory Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, Zhejiang, China. .; International Institutes of Medicine, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Yiwu, Zhejiang, China. .
Cai W; Departments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, WI, 53705, USA. .
Wang K; Department of Respiratory Medicine, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, 322000, Zhejiang, China. .; Pokaż więcej
Źródło:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2353-2374. Date of Electronic Publication: 2023 Mar 16.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Precision Medicine*
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/radiotherapy
Humans ; Radioisotopes/therapeutic use ; Diagnostic Imaging ; Radiopharmaceuticals/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 47.

Tytuł:: A radiohybrid theranostics ligand labeled with fluorine-18 and lutetium-177 for fibroblast activation protein-targeted imaging and radionuclide therapy.
Autorzy:: Yang T; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China.
Peng L; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China.
Qiu J; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China.
He X; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China.
Zhang D; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China.
Wu R; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China.
Liu J; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China.
Zhang X; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China. .
Zha Z; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, #58 Zhongshan Er Road, Guangzhou, 510080, Guangdong Province, China. .; Pokaż więcej
Źródło:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (8), pp. 2331-2341. Date of Electronic Publication: 2023 Mar 03.
Typ publikacji:: Journal Article
MeSH Terms:: Precision Medicine*
Neoplasms*
Mice ; Animals ; Humans ; Tissue Distribution ; Ligands ; Mice, Nude ; Positron-Emission Tomography ; Fluorine Radioisotopes/chemistry ; Gallium Radioisotopes/chemistry ; Fibroblasts ; Cell Line, Tumor ; Positron Emission Tomography Computed Tomography/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 48.

Tytuł:: Dopamine Transporter Deficiency Syndrome (DTDS): Expanding the Clinical Phenotype and Precision Medicine Approaches.
Autorzy:: Ng J; Gene Transfer Technology Group, EGA UCL Institute for Women's Health, University College London, London WC1E 6HX, UK.; Genetic Therapy Accelerator Centre, Queens Square Institute of Neurology, University College London, London WC1N 3BG, UK.
Barral S; Developmental Neurosciences, Zayed Centre for Research into Rare Disease in Children, GOS UCL Institute of Child Health, University College London, London WC1N 1DZ, UK.
Waddington SN; Gene Transfer Technology Group, EGA UCL Institute for Women's Health, University College London, London WC1E 6HX, UK.; Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.
Kurian MA; Developmental Neurosciences, Zayed Centre for Research into Rare Disease in Children, GOS UCL Institute of Child Health, University College London, London WC1N 1DZ, UK.; Paediatric Neurology, Great Ormond Street Hospital for Children, London WC1N 3JH, UK.; Pokaż więcej
Źródło:: Cells [Cells] 2023 Jun 28; Vol. 12 (13). Date of Electronic Publication: 2023 Jun 28.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Dopamine Plasma Membrane Transport Proteins*/genetics
Precision Medicine*
Phenotype
SCR Disease Name:: Parkinsonism-Dystonia, Infantile

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 49.

Tytuł:: Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) Project.
Autorzy:: Morton C; Department of Dermatology, NHS Forth Valley, Stirling, United Kingdom. .
Baharlou S; Department of Dermatology, Skin Immunology & Immune Tolerance (SKIN) Research Group, Vrije Universiteit Brussel, Brussels, Belgium; Universitair Ziekenhuis Brussel, Brussels, Belgium.
Basset-Seguin N; Université de Paris, Paris, France; Hôpital Saint-Louis, Paris, France.
Calzavara-Pinton P; Dermatology Department, University of Brescia, Brescia, Italy.
Dirschka T; CentroDerm Clinic, Wuppertal, Germany.
Gilaberte Y; Department of Dermatology, Miguel Servet University Hospital, IIS Aragón, Zaragoza, Spain.
Haedersdal M; Department of Dermatology, Bispebjerg and Frederiksberg Hospitals, Copenhagen University Hospital, Copenhagen.
Hofbauer G; University Hospital Zürich, University of Zürich, Zürich, Switzerland.
Sapra S; Oakville Trafalgar Memorial Hospital, Oakville, Canada; Institution of Cosmetic and Laser Surgery, Oakville, Canada.
Waalboer-Spuij R; Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Yip L; Skin Partners, Brisbane, Australia.
Szeimies RM; Department of Dermatology & Allergology, Klinikum Vest GmbH Academic Teaching Hospital, Recklinghausen, Germany.; Pokaż więcej
Źródło:: Acta dermato-venereologica [Acta Derm Venereol] 2023 Jun 08; Vol. 103, pp. adv6229. Date of Electronic Publication: 2023 Jun 08.
Typ publikacji:: Journal Article
MeSH Terms:: Keratosis, Actinic*/therapy
Keratosis, Actinic*/drug therapy
Precision Medicine*
Humans

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 50.

Tytuł:: Genetic Influence on Treatment Response in Psoriasis: New Insights into Personalized Medicine.
Autorzy:: Berna-Rico E; Department of Dermatology, Hospital Universitario Ramón y Cajal, IRYCIS, Colmenar Viejo km 9.100, 28034 Madrid, Spain.
Perez-Bootello J; Department of Dermatology, Hospital Universitario Ramón y Cajal, IRYCIS, Colmenar Viejo km 9.100, 28034 Madrid, Spain.
Abbad-Jaime de Aragon C; Department of Dermatology, Hospital Universitario Ramón y Cajal, IRYCIS, Colmenar Viejo km 9.100, 28034 Madrid, Spain.
Gonzalez-Cantero A; Department of Dermatology, Hospital Universitario Ramón y Cajal, IRYCIS, Colmenar Viejo km 9.100, 28034 Madrid, Spain.; Faculty of Medicine, Universidad Francisco de Vitoria, 28223 Madrid, Spain.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jun 07; Vol. 24 (12). Date of Electronic Publication: 2023 Jun 07.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Precision Medicine*
Psoriasis*/drug therapy
Psoriasis*/genetics
Humans ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Methotrexate/therapeutic use ; Polymorphism, Single Nucleotide ; HLA-C Antigens/genetics ; HLA Antigens ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 51.

Tytuł:: Demographic disparities in receipt of care at a comprehensive cancer center.
Autorzy:: Kirtane K; Department of Head and Neck-Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida, USA.; Office of Community Outreach, Engagement, and Equity, Moffitt Cancer Center, Tampa, Florida, USA.
Zhao Y; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Amorrortu RP; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.
Fuzzell LN; Department of Health Outcomes & Behavior, Moffitt Cancer Center, Tampa, Florida, USA.
Vadaparampil ST; Office of Community Outreach, Engagement, and Equity, Moffitt Cancer Center, Tampa, Florida, USA.; Department of Health Outcomes & Behavior, Moffitt Cancer Center, Tampa, Florida, USA.
Rollison DE; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida, USA.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (12), pp. 13687-13700. Date of Electronic Publication: 2023 Apr 28.
Typ publikacji:: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Healthcare Disparities*/ethnology
Healthcare Disparities*/statistics & numerical data
Precision Medicine*/statistics & numerical data
Cancer Care Facilities*/statistics & numerical data
Humans ; Demography ; Hispanic or Latino/statistics & numerical data ; Prostatic Neoplasms/epidemiology ; Prostatic Neoplasms/therapy ; Retrospective Studies ; United States/epidemiology ; White/statistics & numerical data ; Black or African American/statistics & numerical data ; Time-to-Treatment/statistics & numerical data ; National Cancer Institute (U.S.)/statistics & numerical data

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 52.

Tytuł:: The BioLymph study - implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results.
Autorzy:: Smedby KE; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Medicine Solna, div of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
Wästerlid T; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Medicine Solna, div of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
Tham E; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Dept of Clinical Genetics, Karolinska University Hospital Solna, Stockholm, Sweden.
Haider Z; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Joelsson J; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Medicine Solna, div of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
Thorvaldsdottir B; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Krstic A; Dept of Clinical Genetics, Karolinska University Hospital Solna, Stockholm, Sweden.
Wahlin BE; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Medicine Huddinge, Karolinska Institutet.
Foroughi-Asl H
Karlsson C; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Eloranta S; Dept of Medicine Solna, div of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
Saft L; Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Palma M; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Kwiecinska A; Dept of Clinical Pathology and Cancer Diagnostics, Karolinska University Laboratory, Solna and Huddinge, Sweden.
Hansson L; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Österborg A; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Wirta V; Science for Life Laboratory, Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Science for Life Laboratory, Royal Insititute of Technology, Stockholm, Sweden.; Genomic Medicine Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.
Rassidakis G; Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Dept of Clinical Pathology and Cancer Diagnostics, Karolinska University Laboratory, Solna and Huddinge, Sweden.
Sander B; Dept of Clinical Pathology and Cancer Diagnostics, Karolinska University Laboratory, Solna and Huddinge, Sweden.; Dept of Laboratory Medicine, Karolinska Institutet Stockholm, Sweden.
Sonnevi K; Dept of Hematology, Karolinska University Hospital Solna, Sweden.; Dept of Medicine Huddinge, Karolinska Institutet.
Rosenquist R; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Dept of Clinical Genetics, Karolinska University Hospital Solna, Stockholm, Sweden.; Genomic Medicine Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.; Pokaż więcej
Źródło:: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Jun; Vol. 62 (6), pp. 560-564. Date of Electronic Publication: 2023 Jul 06.
Typ publikacji:: Journal Article
MeSH Terms:: Precision Medicine*/methods
Lymphoma*/diagnosis
Lymphoma*/genetics
Lymphoma*/therapy
Humans ; Feasibility Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 53.

Tytuł:: Rare Diseases: Implementation of Molecular Diagnosis, Pathogenesis Insights and Precision Medicine Treatment.
Autorzy:: Larizza L; Experimental Research Laboratory of Medical Cytogenetics and Molecular Genetics, IRCCS Istituto Auxologico Italiano, Via Ariosto 13, 20145 Milan, Italy.
Cubellis MV; Dipartimento di Biologia, Università Federico II, 80126 Naples, Italy.; Biology and Evolution of Marine Organisms, Stazione Zoologica Anton Dohrn, Villa Comunale, 80121 Naples, Italy.; Istituto di Chimica Biomolecolare-CNR, 80078 Pozzuoli, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 May 22; Vol. 24 (10). Date of Electronic Publication: 2023 May 22.
Typ publikacji:: Editorial
MeSH Terms:: Rare Diseases*/diagnosis
Rare Diseases*/genetics
Rare Diseases*/therapy
Precision Medicine*
Humans

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 54.

Tytuł:: Interindividual variation of progesterone elevation post LH rise: implications for natural cycle frozen embryo transfers in the individualized medicine era.
Autorzy:: Coughlan C; ART Fertility Clinic, Dubai, UAE. .; ART Fertility Clinic, Abu Dhabi, UAE. .
Ata B; ART Fertility Clinic, Dubai, UAE.; ART Fertility Clinic, Abu Dhabi, UAE.; Faculty of Medicine, Department of Obstetrics & Gynecology, Koc University, Istanbul, Turkey.
Gallego RD; ART Fertility Clinic, Abu Dhabi, UAE.
Lawrenz B; ART Fertility Clinic, Abu Dhabi, UAE.; Women's University Hospital, Tuebingen, Germany.
Melado L; ART Fertility Clinic, Abu Dhabi, UAE.
Samir S; ART Fertility Clinic, Abu Dhabi, UAE.
Fatemi H; ART Fertility Clinic, Abu Dhabi, UAE.; Pokaż więcej
Źródło:: Reproductive biology and endocrinology : RB&E [Reprod Biol Endocrinol] 2023 May 18; Vol. 21 (1), pp. 47. Date of Electronic Publication: 2023 May 18.
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: Progesterone*
Precision Medicine*
Female ; Humans ; Male ; Luteinizing Hormone ; Menstrual Cycle ; Embryo Transfer

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 55.

Tytuł:: Deep learning in cancer genomics and histopathology.
Autorzy:: Unger M; Else Kroener Fresenius Center for Digital Health, Medical Faculty Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany. .
Kather JN; Else Kroener Fresenius Center for Digital Health, Medical Faculty Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany. jakob_.; Department of Medicine I, University Hospital Dresden, Dresden, Germany. jakob_.; Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany. jakob_.; Pokaż więcej
Źródło:: Genome medicine [Genome Med] 2024 Mar 27; Vol. 16 (1), pp. 44. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Neoplasms*/genetics
Neoplasms*/diagnosis
Deep Learning*
Humans ; Artificial Intelligence ; Precision Medicine/methods ; Genomics/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 56.

Tytuł:: Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine.
Autorzy:: Jose A; Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.
Kulkarni P; Department of Biochemistry, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, 462020, India.
Thilakan J; Department of Biochemistry, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, 462020, India.
Munisamy M; Department of Translational Medicine, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, 462020, India.
Malhotra AG; Department of Translational Medicine, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, 462020, India.
Singh J; Department of Translational Medicine, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, 462020, India.
Kumar A; Department of Biochemistry, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, 462020, India.
Rangnekar VM; Markey Cancer Center and Department of Radiation Medicine, University of Kentucky, Lexington, KY, 40536, USA.
Arya N; Department of Translational Medicine, All India Institute of Medical Sciences Bhopal, Bhopal, Madhya Pradesh, 462020, India. .
Rao M; Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2024 Mar 09; Vol. 23 (1), pp. 50. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Multiomics*
Neoplasms*/drug therapy
Neoplasms*/genetics
Neoplasms*/diagnosis
Humans ; Precision Medicine/methods ; Genomics/methods ; Metabolomics/methods ; Drug Discovery

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 57.

Tytuł:: Activation of the PI3K/AKT signaling pathway by ARNTL2 enhances cellular glycolysis and sensitizes pancreatic adenocarcinoma to erlotinib.
Autorzy:: Ge W; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.; Department of Medical Oncology, Shanghai Medical College, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, People's Republic of China.
Wang Y; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Quan M; Department of Oncology and Tumor Institute, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. .
Mao T; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Bischof EY; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Xu H; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Zhang X; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Li S; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Yue M; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Ma J; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Yang H; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China.
Wang L; Department of Oncology, The Affiliated Lianyungang Hospital of Xuzhou Medical University, The First People's Hospital of Lianyungang, Jiangsu, China.
Yu Z; Department of Medical Oncology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. .
Wang L; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China. .
Cui J; Department of Oncology and State Key Laboratory of Systems Medicine for Cancer of Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, 200127, China. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2024 Mar 08; Vol. 23 (1), pp. 48. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Adenocarcinoma*/drug therapy
Adenocarcinoma*/genetics
Lung Neoplasms*/pathology
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/genetics
Pancreatic Neoplasms*/pathology
Humans ; ARNTL Transcription Factors/metabolism ; Biomarkers/metabolism ; Cell Line, Tumor ; ErbB Receptors/metabolism ; Erlotinib Hydrochloride/pharmacology ; Phosphatidylinositol 3-Kinases/metabolism ; Phosphorylation ; Precision Medicine ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 58.

Tytuł:: Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response.
Autorzy:: Smabers LP; Department of Medical Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
Wensink E; Department of Medical Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
Verissimo CS; HUB Organoids B.V, Utrecht, The Netherlands.
Koedoot E; HUB Organoids B.V, Utrecht, The Netherlands.
Pitsa KC; HUB Organoids B.V, Utrecht, The Netherlands.
Huismans MA; Molecular Cancer Research, Center for Molecular Medicine, UMCU, Utrecht, The Netherlands.
Higuera Barón C; HUB Organoids B.V, Utrecht, The Netherlands.
Doorn M; HUB Organoids B.V, Utrecht, The Netherlands.
Valkenburg-van Iersel LB; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands.
Cirkel GA; Department of Medical Oncology, Meander Medical Center, Amersfoort, The Netherlands.
Brousali A; Utrecht Platform for Organoid Technology (UPORT), UMCU, Utrecht, The Netherlands.
Overmeer R; HUB Organoids B.V, Utrecht, The Netherlands.
Koopman M; Department of Medical Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
Braat MN; Department of Radiology, UMCU, Utrecht, The Netherlands.
Penning de Vries B; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, UMCU, Utrecht, The Netherlands.
Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, UMCU, Utrecht, The Netherlands.
Vries RG; HUB Organoids B.V, Utrecht, The Netherlands.
Kranenburg O; Utrecht Platform for Organoid Technology (UPORT), UMCU, Utrecht, The Netherlands.; Laboratory of Translational Oncology, Division of Imaging and Cancer, UMCU, Utrecht, The Netherlands.
Boj SF; HUB Organoids B.V, Utrecht, The Netherlands. .
Roodhart JM; Department of Medical Oncology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Feb 27; Vol. 43 (1), pp. 61. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:: Journal Article
MeSH Terms:: Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Colonic Neoplasms*/drug therapy
Humans ; Irinotecan/pharmacology ; Irinotecan/therapeutic use ; Oxaliplatin/pharmacology ; Oxaliplatin/therapeutic use ; Acetylcysteine/therapeutic use ; Precision Medicine ; Fluorouracil/pharmacology ; Fluorouracil/therapeutic use ; Organoids ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 59.

Tytuł:: Genetics and beyond: Precision Medicine Real-World Data for Patients with Cervical, Vaginal or Vulvar Cancer in a Tertiary Cancer Center.
Autorzy:: Kraus FBT; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Munich, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.; Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Sultova E; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Munich, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Heinrich K; Department of Medicine III, Comprehensive Cancer Center Munich, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Jung A; Institute of Pathology, Comprehensive Cancer Center Munich, LMU University Hospital, Ludwig Maximilians University (LMU), 81377 Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, 81377 Munich, Germany.
Westphalen CB; Department of Medicine III, Comprehensive Cancer Center Munich, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, 81377 Munich, Germany.
Tauber CV; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Munich, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Kumbrink J; Institute of Pathology, Comprehensive Cancer Center Munich, LMU University Hospital, Ludwig Maximilians University (LMU), 81377 Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, 81377 Munich, Germany.
Rudelius M; Institute of Pathology, Comprehensive Cancer Center Munich, LMU University Hospital, Ludwig Maximilians University (LMU), 81377 Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, 81377 Munich, Germany.
Klauschen F; Institute of Pathology, Comprehensive Cancer Center Munich, LMU University Hospital, Ludwig Maximilians University (LMU), 81377 Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, 81377 Munich, Germany.
Greif PA; Department of Medicine III, Comprehensive Cancer Center Munich, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, 81377 Munich, Germany.; German Cancer Research Center (DKFZ), 69121 Heidelberg, Germany.
König A; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Munich, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Chelariu-Raicu A; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Munich, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Czogalla B; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Munich, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Burges A; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Munich, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Mahner S; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Munich, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Wuerstlein R; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Munich, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Trillsch F; Department of Obstetrics and Gynecology, Comprehensive Cancer Center Munich, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 16; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 16.
Typ publikacji:: Journal Article
MeSH Terms:: Vulvar Neoplasms*/genetics
Vulvar Neoplasms*/therapy
Vulvar Neoplasms*/pathology
Genital Neoplasms, Female*/drug therapy
Genital Neoplasms, Female*/genetics
Papillomavirus Infections*/complications
Papillomavirus Infections*/genetics
Humans ; Female ; Precision Medicine ; Retrospective Studies ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 60.

Tytuł:: Epidermal Growth Factor Receptor Inhibitors in Glioblastoma: Current Status and Future Possibilities.
Autorzy:: Ezzati S; California Northstate University College of Medicine, Elk Grove, CA 95757, USA.
Salib S; California Northstate University College of Medicine, Elk Grove, CA 95757, USA.
Balasubramaniam M; Reynolds Institute on Aging, Department of Geriatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Aboud O; Department of Neurology, Department of Neurological Surgery, Comprehensive Cancer Center, University of California, Davis, Sacramento, CA 95817, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 15; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Brain Neoplasms*/drug therapy
ErbB Receptors*/antagonists & inhibitors
Glioblastoma*/drug therapy
Protein Kinase Inhibitors*/pharmacology
Protein Kinase Inhibitors*/therapeutic use
Adult ; Humans ; Precision Medicine ; Signal Transduction

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Precision"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji